Cleared Traditional

LARIAT PALATE EXPANDER (K926427) - FDA 510(k) Clearance

Class I Dental device.

K926427 · Easy Access Orthodontics, Inc. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1994
Decision
399d
Days
Class 1
Risk

K926427 is an FDA 510(k) clearance for the LARIAT PALATE EXPANDER. Classified as Bracket, Metal, Orthodontic (product code EJF), Class I - General Controls.

Submitted by Easy Access Orthodontics, Inc. (Mission Viejo, US). The FDA issued a Cleared decision on January 26, 1994 after a review of 399 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.5410 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Easy Access Orthodontics, Inc. devices

Submission Details

510(k) Number K926427 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 1992
Decision Date January 26, 1994
Days to Decision 399 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
272d slower than avg
Panel avg: 127d · This submission: 399d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code EJF Bracket, Metal, Orthodontic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.5410
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.